Details for 2014778339
Up to date per 03.04.2026
Actions
Details for 2014778339
Granted/Registered
European Patent
10.02.2016 A
12.08.2020 B1
05.04.2013
US
201361808962 P
A61K 31/341 20060101AFI20160825BHEP
Owner
ScPharmaceuticals Inc.2400 District Avenue, Suite 310 Burlington, MA 01803US
Representative
No representatives present
Inventor
MICHAELS, Scott, A.c/o scPharmaceuticals LLC 75 Arlington Street Boston, Massachusetts 02116US
MUNTENDAM, Pieterc/o scPharmaceuticals LLC 75 Arlington Street Boston, Massachusetts 02116US
LARSEN, Glenn, R.c/o scPharmaceuticals LLC 75 Arlington Street Boston, Massachusetts 02116US
Information about Fees